Projects

Cost-benefit analysis is one of the tools commonly used in policy-making: it provides a clear framework for the comparison of the costs and benefits of action (or no-action). Although in some cases a qualitative analysis is sufficient to produce adequate information for a robust conclusion, quantification does bring an added value to the decision making process. 

The costs of an action are usually expressed in monetary values; on the other side, benefits quite often do not have a market value and thus other information is required to attempt monetary valuation through, for example, a benefit transfer. 

Furthermore, when assessing policy initiatives in the chemicals domain, lack of information and uncertainty need to be dealt with at different levels:

  • Mechanisms of action of chemicals on human health and the environment;
  • Routes and levels of exposure, together with the population exposed;
  • Decrease in the levels of exposure obtained by a policy action.

The overall aim of this project is to define a set of indicators for the assessment and monitoring of the human health and environmental benefits delivered by the European legislative framework for chemicals.

Related Services

Related Sectors

Latest News

RPA report the basis of stakeholder consultation on MCCPs in electrical and electronic equipment RPA has supported the Swedish Chemicals Agency (KEMI) by preparing a two-phase impact assessment which looked into the implications of […]
REACH Authorisation Success for Rimex Metals as Annex XIV updated On 24 May 2017, the European Commission published their summary decision on Rimex Metals (UK) Ltd’s Application for the Authorisation […]